Showing results (2581-2590 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|September 3, 2024
Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinomaZhiwei Li, Xiaona Fan, Dan Jiang, et al.
The Oncologist|August 27, 2024
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT studyErkut H Borazanci, Nathan Bahary, Vincent Chung, et al.
The Oncologist|August 23, 2024
Systemic inflammation and changes in physical well-being in patients with breast cancer: a longitudinal study in community oncology settingsNikesha Gilmore, Yue Li, Christopher L Seplaki, et al.
The Oncologist|August 24, 2024
Arm symptom pattern among breast cancer survivors with and without lymphedema: a contemporaneous network analysisAomei Shen, Zhongning Zhang, Jingming Ye, et al.
The Oncologist|August 21, 2024
Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinomaTian Zhang, Alan Tan, Amishi Y Shah, et al.
The Oncologist|August 23, 2024
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational studyFrancesco Schettini, Marianna Sirico, Marco Loddo, et al.
The Oncologist|November 28, 2024
Hospital care trajectories of older adults with cancer and the associated clinical profilesCharline Jean, Elena Paillaud, Pascaline Boudou-Rouquette, et al.
The Oncologist|November 27, 2024
Triage performance of DNA methylation for women with high-risk human papillomavirus infectionLinghua Kong, Xiaoping Xiao, Huanwen Wu, et al.
The Oncologist|November 20, 2024
Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancerWen-Kuan Huang, Yan-Jei Tang, Chiao-En Wu, et al.
The Oncologist|November 20, 2024
Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitorsJarushka Naidoo, Douglas B Johnson, Charlotte Doran, et al.
Pageof 571